{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T16:56:32Z","timestamp":1791046592694,"version":"4.1.0"},"reference-count":239,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["62122017"],"award-info":[{"award-number":["62122017"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Talanta"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.talanta.2023.124996","type":"journal-article","created":{"date-parts":[[2023,7,27]],"date-time":"2023-07-27T05:53:32Z","timestamp":1690437212000},"page":"124996","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":96,"special_numbering":"P1","title":["Overview of therapeutic drug monitoring and clinical practice"],"prefix":"10.1016","volume":"266","author":[{"given":"Zijun","family":"Fang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"He","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiuchuan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2659-3150","authenticated-orcid":false,"given":"Jinhong","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"17","key":"10.1016\/j.talanta.2023.124996_bib1","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25174026","article-title":"\"Review of chromatographic methods coupled with modern detection techniques applied in the therapeutic drugs monitoring (TDM).\"","volume":"25","author":"Tuzimski","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.talanta.2023.124996_bib183","first-page":"54","article-title":"Therapeutic drug monitoring of immunosuppressive drugs in hepatology and gastroenterology","author":"Udomkarnjananun","year":"2021","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"key":"10.1016\/j.talanta.2023.124996_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2021.114315","article-title":"\"Overview of therapeutic drug monitoring of immunosuppressive drugs: analytical and clinical practices.\"","volume":"205","author":"Seyfinejad","year":"2021","journal-title":"J. Pharmaceut. Biomed. Anal."},{"issue":"2","key":"10.1016\/j.talanta.2023.124996_bib196","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.cvex.2018.01.003","article-title":"Techniques for monitoring drug efficacy (review) [J]","volume":"21","author":"Marike Visser","year":"2018","journal-title":"Vet. Clin. Exot. Anim. Pract."},{"issue":"5","key":"10.1016\/j.talanta.2023.124996_bib197","doi-asserted-by":"crossref","first-page":"393","DOI":"10.2217\/bmm-2018-0355","article-title":"Pharmacodynamic monitoring using biomarkers to individualize pharmacotherapy","volume":"13","author":"Theile","year":"2019","journal-title":"Biomarkers Med."},{"issue":"5","key":"10.1016\/j.talanta.2023.124996_bib198","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1053\/j.gastro.2022.02.014","article-title":"Optimizing therapies using therapeutic drug monitoring: current strategies and future perspectives [J]","volume":"162","author":"Irving","year":"2022","journal-title":"Gastroenterology"},{"key":"10.1016\/j.talanta.2023.124996_bib199","series-title":"Saliva Sampling in Therapeutic Drug Monitoring and Physiologically Based Pharmacokinetic Modeling: Review [J]","author":"May","year":"2022"},{"issue":"9","key":"10.1016\/j.talanta.2023.124996_bib200","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1021\/acssensors.0c01318","article-title":"Wearable electrochemical sensors for the monitoring and screening of drugs [J]","volume":"5","author":"Teymourian","year":"2020","journal-title":"ACS Sens."},{"issue":"4","key":"10.1016\/j.talanta.2023.124996_bib201","doi-asserted-by":"crossref","first-page":"132","DOI":"10.3390\/bios9040132","article-title":"Optical biosensors for therapeutic drug monitoring","volume":"9","author":"Garz\u00f3n","year":"2019","journal-title":"Biosensors"},{"issue":"1","key":"10.1016\/j.talanta.2023.124996_bib24","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/dta.2290","article-title":"Recent advances in analytical methods for the therapeutic drug monitoring of immunosuppressive drugs","volume":"10","author":"Zhang","year":"2018","journal-title":"Drug Test. Anal."},{"issue":"8","key":"10.1016\/j.talanta.2023.124996_bib163","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1080\/15622975.2021.1878427","article-title":"\"Tools for optimising pharmacotherapy in psychiatry (therapeutic drug monitoring, molecular brain imaging and pharmacogenetic tests)","volume":"22","author":"Eap","year":"2021","journal-title":"Focus World J. Biol. Psychiatr."},{"issue":"24","key":"10.1016\/j.talanta.2023.124996_bib202","first-page":"1764","article-title":"[Therapeutic drug monitoring of antiinfectives in intensive care unit patients - what's new?] [J]","volume":"145","author":"K\u00f6nig","year":"2020","journal-title":"Dtsch. Med. Wochenschr."},{"issue":"1","key":"10.1016\/j.talanta.2023.124996_bib237","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/FTD.0000000000000942","article-title":"Therapeutic drug monitoring of antibiotics in critically ill patients: current practice and future perspectives with a focus on clinical outcome","volume":"44","author":"Koch","year":"2022","journal-title":"Ther. Drug Monit."},{"issue":"2","key":"10.1016\/j.talanta.2023.124996_bib238","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.gtc.2021.12.007","article-title":"Therapeutic drug monitoring of biologics in Crohn?s disease","volume":"51","author":"Grossberg","year":"2022","journal-title":"Gastroenterol. Clin. N. Am."},{"key":"10.1016\/j.talanta.2023.124996_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2021.114315","article-title":"Overview of therapeutic drug monitoring of immunosuppressive drugs: analytical and clinical practices","volume":"205","author":"Seyfinejad","year":"2021","journal-title":"J. Pharmaceut. Biomed. Anal."},{"issue":"5","key":"10.1016\/j.talanta.2023.124996_bib184","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1053\/j.gastro.2022.02.014","article-title":"Optimizing therapies using therapeutic drug monitoring: current strategies and future perspectives","volume":"162","author":"Irving","year":"2022","journal-title":"Gastroenterology"},{"issue":"11","key":"10.1016\/j.talanta.2023.124996_bib187","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13111915","article-title":"Chronopharmacology in therapeutic drug monitoring-dependencies between the Rhythmics of pharmacokinetic processes and drug concentration in blood","volume":"13","author":"Dobrek","year":"2021","journal-title":"Pharmaceutics"},{"issue":"6","key":"10.1016\/j.talanta.2023.124996_bib171","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1097\/FTD.0000000000000103","article-title":"The need for tacrolimus assay standardization","volume":"36","author":"Filler","year":"2014","journal-title":"Ther. Drug Monit."},{"issue":"4","key":"10.1016\/j.talanta.2023.124996_bib192","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1093\/jpids\/piaa078","article-title":"A moving target-vancomycin therapeutic monitoring","volume":"9","author":"Burns","year":"2020","journal-title":"J. Pediatr. Infect. Dis. Soc."},{"key":"10.1016\/j.talanta.2023.124996_bib52","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jpba.2019.02.001","article-title":"Therapeutic drug monitoring of teicoplanin using an LC-MS\/MS method: analysis of 421 measurements in a naturalistic clinical setting","volume":"167","author":"Jung","year":"2019","journal-title":"J. Pharmaceut. Biomed. Anal."},{"issue":"1","key":"10.1016\/j.talanta.2023.124996_bib239","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/FTD.0000000000000936","article-title":"Therapeutic drug monitoring of anti-infective drugs: implementation strategies for 3 different scenarios","volume":"44","author":"Kim","year":"2022","journal-title":"Ther. Drug Monit."},{"issue":"4","key":"10.1016\/j.talanta.2023.124996_bib11","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1080\/10408347.2018.1527206","article-title":"Modern assay techniques for cancer drugs: electroanalytical and liquid chromatography methods","volume":"49","author":"Kurbanoglu","year":"2019","journal-title":"Crit. Rev. Anal. Chem."},{"issue":"5","key":"10.1016\/j.talanta.2023.124996_bib185","doi-asserted-by":"crossref","DOI":"10.1002\/bmc.5347","article-title":"Cutting-edge LC-MS\/MS applications in clinical mass spectrometry: focusing on analysis of drugs and metabolites","volume":"36","author":"Maekawa","year":"2022","journal-title":"Biomed. Chromatogr."},{"issue":"4","key":"10.1016\/j.talanta.2023.124996_bib191","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/FTD.0000000000000525","article-title":"Mass spectrometry for research and application in therapeutic drug monitoring or clinical and forensic Toxicology","volume":"40","author":"Maurer","year":"2018","journal-title":"Ther. Drug Monit."},{"issue":"5","key":"10.1016\/j.talanta.2023.124996_bib177","doi-asserted-by":"crossref","DOI":"10.1002\/bmc.5347","article-title":"Cutting-edge LC-MS\/MS applications in clinical mass spectrometry: focusing on analysis of drugs and metabolites","volume":"36","author":"Maekawa","year":"2022","journal-title":"Biomed. Chromatogr."},{"issue":"4","key":"10.1016\/j.talanta.2023.124996_bib179","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27041224","article-title":"LC-MS3 strategy for quantification of carbamazepine in human plasma and its application in therapeutic drug monitoring","volume":"27","author":"Ma","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.talanta.2023.124996_bib180","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jmsacl.2022.02.001","article-title":"An UHPLC-MS\/MS method for quantification of the CDK4\/6 inhibitor abemaciclib in human serum","volume":"24","author":"Habler","year":"2022","journal-title":"J. Mass Spectrom. Adv. Clin. Lab."},{"key":"10.1016\/j.talanta.2023.124996_bib182","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/7048605","article-title":"UPLC-MS\/MS method for simultaneous determination of 14 antimicrobials in human plasma and cerebrospinal fluid: application to therapeutic drug monitoring","volume":"2022","author":"Sun","year":"2022","journal-title":"J. Anal. Methods Chem."},{"key":"10.1016\/j.talanta.2023.124996_bib4","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.cca.2019.01.023","article-title":"Advances in antifungal drug measurement by liquid chromatography-mass spectrometry","volume":"491","author":"Zheng","year":"2019","journal-title":"Clin. Chim. Acta"},{"issue":"1","key":"10.1016\/j.talanta.2023.124996_bib181","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-06638-1","article-title":"Two-dimensional temperature-responsive chromatography using a poly(N-isopropylacrylamide) brush-modified stationary phase for effective therapeutic drug monitoring","volume":"12","author":"Nagase","year":"2022","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.talanta.2023.124996_bib5","first-page":"27","article-title":"Bioanalysis of aminoglycosides using high-performance liquid chromatography","volume":"10","author":"Amponsah","year":"2022","journal-title":"Admet & Dmpk"},{"key":"10.1016\/j.talanta.2023.124996_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2021.122750","article-title":"High performance liquid chromatography: a versatile tool for assaying antiepileptic drugs in biological matrices","volume":"1179","author":"Opuni","year":"2021","journal-title":"J. Chromatogr., B: Anal. Technol. Biomed. Life Sci."},{"issue":"5","key":"10.1016\/j.talanta.2023.124996_bib178","doi-asserted-by":"crossref","DOI":"10.1002\/bmc.5306","article-title":"Developing LC-MS\/MS methods to quantify rivaroxabanin human plasma and urine: application to therapeutic drug monitoring","volume":"36","author":"Zheng","year":"2022","journal-title":"Biomed. Chromatogr."},{"issue":"1","key":"10.1016\/j.talanta.2023.124996_bib7","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s40199-021-00391-y","article-title":"HPLC methods for choloroquine determination in biological samples and pharmaceutical products","volume":"29","author":"Martins","year":"2021","journal-title":"Daru"},{"issue":"1","key":"10.1016\/j.talanta.2023.124996_bib8","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/dta.2290","article-title":"Recent advances in analytical methods for the therapeutic drug monitoring of immunosuppressive drugs","volume":"10","author":"Zhang","year":"2018","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.talanta.2023.124996_bib26","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jchromb.2019.04.020","article-title":"Advances in capillary electrophoresis for the life sciences","volume":"1118","author":"Torano","year":"2019","journal-title":"J. Chromatogr., B: Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.talanta.2023.124996_bib9","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/978-1-0716-2325-1_6","article-title":"Capillary isoelectric focusing: mass spectrometry method for the separation and online characterization of monoclonal antibody charge variants at intact and subunit levels","volume":"2500","author":"Dai","year":"2022","journal-title":"Methods Mol. Biol."},{"issue":"1","key":"10.1016\/j.talanta.2023.124996_bib10","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.drudis.2020.10.021","article-title":"Electrochemical biosensors: a nexus for precision medicine","volume":"26","author":"Pollard","year":"2021","journal-title":"Drug Discov. Today"},{"issue":"10","key":"10.1016\/j.talanta.2023.124996_bib186","article-title":"Recent progress in microneedles-mediated diagnosis, therapy, and Theranostic systems","volume":"11","author":"Yang","year":"2022","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.talanta.2023.124996_bib12","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.jelechem.2017.08.034","article-title":"A novel electrochemical sensor based on electrospun TiO2 nanoparticles\/carbon nanofibers for determination of Idarubicin in biological samples","volume":"801","author":"Arkan","year":"2017","journal-title":"J. Electroanal. Chem."},{"key":"10.1016\/j.talanta.2023.124996_bib13","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.jelechem.2017.08.032","article-title":"A layer-by-layer sensing architecture based on dendrimer and ionic liquid supported reduced graphene oxide for simultaneous hollow-fiber solid phase microextraction and electrochemical determination of anti-cancer drug imatinib in biological samples","volume":"801","author":"Hatamluyi","year":"2017","journal-title":"J. Electroanal. Chem."},{"issue":"2","key":"10.1016\/j.talanta.2023.124996_bib14","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1093\/clinchem\/44.2.375","article-title":"Analytical goals in therapeutic drug monitoring","volume":"44","author":"Bowers","year":"1998","journal-title":"Clin. Chem."},{"issue":"21","key":"10.1016\/j.talanta.2023.124996_bib172","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25215083","article-title":"New methods used in pharmacokinetics and therapeutic monitoring of the first and newer generations of antiepileptic drugs (AEDs)","volume":"25","author":"Sommerfeld-Klatta","year":"2020","journal-title":"Molecules"},{"issue":"3","key":"10.1016\/j.talanta.2023.124996_bib173","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1080\/17425255.2020.1724956","article-title":"Therapeutic drug monitoring of antiepileptic drugs: current status and future prospects","volume":"16","author":"Johannessen Landmark","year":"2020","journal-title":"Expet Opin. Drug Metabol. Toxicol."},{"issue":"1","key":"10.1016\/j.talanta.2023.124996_bib174","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1373\/jalm.2017.023689","article-title":"Clinical use and monitoring of antiepileptic drugs","volume":"3","author":"Knezevic","year":"2018","journal-title":"J. Appl. Lab. Med."},{"issue":"17\u201318","key":"10.1016\/j.talanta.2023.124996_bib175","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1080\/10826076.2016.1266654","article-title":"The use of separation techniques in the analysis of some antiepileptic drugs: a critical review","volume":"39","author":"Mohamed","year":"2016","journal-title":"J. Liq. Chromatogr. Relat. Technol."},{"key":"10.1016\/j.talanta.2023.124996_bib15","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.microc.2016.09.007","article-title":"Determination of lamotrigine in human plasma and saliva using microextraction by packed sorbent and high-performance liquid chromatography-diode array detection: an innovative bioanalytical tool for therapeutic drug monitoring","volume":"130","author":"Ventura","year":"2017","journal-title":"Microchem. J."},{"key":"10.1016\/j.talanta.2023.124996_bib16","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.chroma.2019.06.022","article-title":"Fully automated therapeutic drug monitoring of anti-epileptic drugs making use of dried blood spots","volume":"1601","author":"Velghe","year":"2019","journal-title":"J. Chromatogr. A"},{"issue":"1","key":"10.1016\/j.talanta.2023.124996_bib17","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jpba.2010.02.036","article-title":"Simultaneous HPLC-F analysis of three recent antiepileptic drugs in human plasma","volume":"53","author":"Mercolini","year":"2010","journal-title":"J. Pharmaceut. Biomed. Anal."},{"issue":"9","key":"10.1016\/j.talanta.2023.124996_bib18","doi-asserted-by":"crossref","DOI":"10.1007\/s00216-018-0866-4","article-title":"Volumetric absorptive microsampling as an alternative tool for therapeutic drug monitoring of first-generation anti-epileptic drugs (vol 410, pg 2331, 2018)","volume":"410","author":"Velghe","year":"2018","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.talanta.2023.124996_bib19","article-title":"Fast liquid chromatography-tandem mass spectrometry method for simultaneous determination of eight antiepileptic drugs and an active metabolite in human plasma using polarity switching and timed selected reaction monitoring","volume":"176","author":"Liu","year":"2019","journal-title":"J. Pharmaceut. Biomed. Anal."},{"issue":"7","key":"10.1016\/j.talanta.2023.124996_bib195","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1080\/10408347.2021.1890544","article-title":"Stability indicating methods for determination of third generation antiepileptic drugs and their related substances","volume":"52","author":"da Silva","year":"2022","journal-title":"Crit. Rev. Anal. Chem."},{"issue":"2","key":"10.1016\/j.talanta.2023.124996_bib189","doi-asserted-by":"crossref","first-page":"105","DOI":"10.15171\/bi.2019.14","article-title":"Determination of valproic acid and 3-heptanone in plasma using air-assisted liquid-liquid microextraction with the assistance of vortex: application in the real samples","volume":"9","author":"Feriduni","year":"2019","journal-title":"Bioimpacts"},{"issue":"12","key":"10.1016\/j.talanta.2023.124996_bib20","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.5858\/arpa.2020-0562-CP","article-title":"Therapeutic drug monitoring of second- and third-generation antiepileptic drugs insights from a college of American pathologists proficiency testing survey","volume":"145","author":"Krasowski","year":"2021","journal-title":"Arch. Pathol. Lab Med."},{"issue":"7","key":"10.1016\/j.talanta.2023.124996_bib21","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.22940","article-title":"Comparison of performance characteristics between high-performance liquid chromatography and latex agglutination turbidimetric immunoassay for therapeutic drug monitoring of zonisamide","volume":"33","author":"Eto","year":"2019","journal-title":"J. Clin. Lab. Anal."},{"issue":"E1","key":"10.1016\/j.talanta.2023.124996_bib22","doi-asserted-by":"crossref","first-page":"E2","DOI":"10.1136\/ejhpharm-2018-001616","article-title":"Therapeutic drug monitoring of levetiracetam in daily clinical practice: high-performance liquid chromatography versus immunoassay","volume":"27","author":"Mendoza Aguilera","year":"2020","journal-title":"Eur. J. Hosp. Pharm."},{"issue":"1","key":"10.1016\/j.talanta.2023.124996_bib23","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.22157","article-title":"Comparison of LC-MS\/MS vs chemiluminescent microparticle immunoassay in measuring the valproic acid concentration in plasma of epilepsy patients in a new perspective","volume":"32","author":"Wang","year":"2018","journal-title":"J. Clin. Lab. Anal."},{"issue":"1","key":"10.1016\/j.talanta.2023.124996_bib203","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/dta.3362","article-title":"Valproic acid determination by liquid chromatography coupled to mass spectrometry (LC-MS\/MS) in whole blood for forensic purposes","volume":"15","author":"Pascali","year":"2023","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.talanta.2023.124996_bib204","first-page":"2047","article-title":"Analytical and clinical validation of an LC-MS\/MS method for carbamazepine, lamotrigine and levetiracetam in dried blood spots","author":"den Besten-Bertholee","year":"2023","journal-title":"Eur. J. Hosp. Pharm."},{"issue":"5","key":"10.1016\/j.talanta.2023.124996_bib205","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2174\/1573412917666210215150712","article-title":"Comparison of HPLC-DAD and UPLC-MS\/MS in monitoring serum concentration of lamotrigine","volume":"18","author":"Wang","year":"2022","journal-title":"Curr. Pharmaceut. Anal."},{"issue":"No.2","key":"10.1016\/j.talanta.2023.124996_bib206","doi-asserted-by":"crossref","first-page":"228","DOI":"10.2174\/1573412917666210211122311","article-title":"Ultra-performance liquid chromatography coupled with a triple quadrupole mass spectrometric method for the quantification of antiepileptic drugs methsuximide and Normesuximide in human plasma and its application in a pharmacokinetic study","volume":"18","author":"Rajendran","year":"2022","journal-title":"Curr. Pharmaceut. Anal."},{"issue":"43","key":"10.1016\/j.talanta.2023.124996_bib207","doi-asserted-by":"crossref","first-page":"39097","DOI":"10.1021\/acsomega.2c04865","article-title":"Electrochemical carbamazepine aptasensor for therapeutic drug monitoring at the point of care","volume":"7","author":"Chung","year":"2022","journal-title":"ACS Omega"},{"issue":"6","key":"10.1016\/j.talanta.2023.124996_bib208","doi-asserted-by":"crossref","DOI":"10.3390\/s23063271","article-title":"Disposable sensor chips with molecularly imprinted carbon paste electrodes for monitoring anti-epileptic drugs","volume":"23","author":"Aaryashree","year":"2023","journal-title":"Sensors"},{"issue":"2","key":"10.1016\/j.talanta.2023.124996_bib25","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.gtc.2018.01.003","article-title":"Immunologic monitoring to personalize immunosuppression after liver transplant","volume":"47","author":"Zhu","year":"2018","journal-title":"Gastroenterol. Clin. N. Am."},{"key":"10.1016\/j.talanta.2023.124996_bib27","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/BF02492191","article-title":"Determination of mycophenolic acid and its glucuronide conjugate in human plasma by capillary electrophoresis [J]","volume":"54","author":"\u00dcnsalan","year":"2001","journal-title":"Chromatographia"},{"issue":"1","key":"10.1016\/j.talanta.2023.124996_bib28","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jpba.2007.12.028","article-title":"Simultaneous determination of mycophenolic acid and its acyl and phenol glucuronide metabolites in human serum by capillary zone electrophoresis","volume":"47","author":"Ohyama","year":"2008","journal-title":"J. Pharmaceut. Biomed. Anal."},{"issue":"17","key":"10.1016\/j.talanta.2023.124996_bib29","doi-asserted-by":"crossref","first-page":"3658","DOI":"10.1002\/elps.200700952","article-title":"A simple and rapid CZE method for the analysis of mycophenolic acid and its phenol glucuronide metabolite in human serum","volume":"29","author":"Ohyama","year":"2008","journal-title":"Electrophoresis"},{"issue":"1","key":"10.1016\/j.talanta.2023.124996_bib30","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s00216-004-2687-x","article-title":"Trace analysis of rapamycin in human blood by micellar electrokinetic chromatography","volume":"380","author":"Buchberger","year":"2004","journal-title":"Anal. Bioanal. Chem."},{"issue":"20","key":"10.1016\/j.talanta.2023.124996_bib31","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1002\/elps.201800081","article-title":"Simultaneous electrokinetic and hydrodynamic injection and sequential stacking featuring sweeping for signal amplification following MEKC during the analysis of rapamycin (sirolimus) in serum samples","volume":"39","author":"Oledzka","year":"2018","journal-title":"Electrophoresis"},{"key":"10.1016\/j.talanta.2023.124996_bib32","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jchromb.2017.12.012","article-title":"Development of a fast HPLC-DAD method for simultaneous quantitation of three immunosuppressant drugs in whole blood samples using intelligent chemometrics resolving of coeluting peaks in the presence of blood interferences","volume":"1073","author":"Vosough","year":"2018","journal-title":"J. Chromatogr., B: Anal. Technol. Biomed. Life Sci."},{"issue":"13\u201314","key":"10.1016\/j.talanta.2023.124996_bib33","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.clinbiochem.2016.06.013","article-title":"Experiences from using LC-MS\/MS for analysis of immunosuppressive drugs in a TDM service","volume":"49","author":"Pohanka","year":"2016","journal-title":"Clin. Biochem."},{"issue":"16","key":"10.1016\/j.talanta.2023.124996_bib190","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.4155\/bio-2019-0143","article-title":"A multidrug LC-MS\/MS method for the determination of five immunosuppressants in oral fluid","volume":"11","author":"Paniagua-Gonzalez","year":"2019","journal-title":"Bioanalysis"},{"key":"10.1016\/j.talanta.2023.124996_bib34","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jchromb.2013.03.014","article-title":"Two rapid ultra performance liquid chromatography\/tandem mass spectrometry (UPLC\/MS\/MS) methods with common sample pretreatment for therapeutic drug monitoring of immunosuppressants compared to immunoassay","volume":"928","author":"Tszyrsznic","year":"2013","journal-title":"J. Chromatogr., B: Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.talanta.2023.124996_bib35","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jchromb.2012.04.006","article-title":"Determination of four immunosuppressive drugs in whole blood using MEPS and LC-MS\/MS allowing automated sample work-up and analysis","volume":"897","author":"Said","year":"2012","journal-title":"J. Chromatogr., B: Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.talanta.2023.124996_bib36","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.aca.2017.10.016","article-title":"Rapid determination of immunosuppressive drug concentrations in whole blood by coated blade spray-tandem mass spectrometry (CBS-MS\/MS)","volume":"999","author":"Gomez-Rios","year":"2018","journal-title":"Anal. Chim. Acta"},{"issue":"8","key":"10.1016\/j.talanta.2023.124996_bib37","doi-asserted-by":"crossref","DOI":"10.1002\/bmc.4853","article-title":"Development of a precise quantitative method for monitoring sirolimus in whole blood using LC\/ESI-MS\/MS","volume":"34","author":"Shigeta","year":"2020","journal-title":"Biomed. Chromatogr."},{"issue":"5","key":"10.1016\/j.talanta.2023.124996_bib38","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1016\/j.transproceed.2020.01.077","article-title":"Simultaneous determination of everolimus, sirolimus, tacrolimus, and cyclosporine-A by mass spectrometry","volume":"52","author":"Perez","year":"2020","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.talanta.2023.124996_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2020.122303","article-title":"Size exclusion chromatography: an effective tool for the estimation of Sirolimus levels","volume":"1156","author":"Sreejith","year":"2020","journal-title":"J. Chromatogr., B: Anal. Technol. Biomed. Life Sci."},{"issue":"4","key":"10.1016\/j.talanta.2023.124996_bib40","doi-asserted-by":"crossref","first-page":"475","DOI":"10.5582\/bst.2017.01121","article-title":"A comparison of liquid chromatography-tandem mass spectrometry (LC-MS\/MS) and enzyme-multiplied immunoassay technique (EMIT) for the determination of the cyclosporin A concentration in whole blood from Chinese patients","volume":"11","author":"Li","year":"2017","journal-title":"Biosci. Trends"},{"key":"10.1016\/j.talanta.2023.124996_bib41","doi-asserted-by":"crossref","DOI":"10.1177\/2010105820974385","article-title":"Impact of transiting from fluorescent polarisation immunoassay to high-performance liquid chromatography-tandem mass spectrometry for immunosuppressant levels analysis in kidney transplant patients","volume":"29","author":"Goh","year":"2020","journal-title":"Proc. Singapore Healthc."},{"key":"10.1016\/j.talanta.2023.124996_bib42","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jchromb.2018.04.028","article-title":"Simultaneous determination of cyclosporine and tacrolimus in human whole blood by ultra-high performance liquid chromatography tandem mass spectrometry and comparison with a chemiluminescence microparticle immunoassay","volume":"1087","author":"Mei","year":"2018","journal-title":"J. Chromatogr., B: Anal. Technol. Biomed. Life Sci."},{"issue":"3","key":"10.1016\/j.talanta.2023.124996_bib43","doi-asserted-by":"crossref","DOI":"10.3892\/etm.2021.9623","article-title":"Validation of a novel UPLC-HRMS method for human whole-blood cyclosporine and comparison with a CMIA immunoassay","volume":"21","author":"Wang","year":"2021","journal-title":"Exp. Ther. Med."},{"issue":"2\u20133","key":"10.1016\/j.talanta.2023.124996_bib44","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.clinbiochem.2010.10.005","article-title":"Comparison of blood sirolimus, tacrolimus and everolimus concentrations measured by LC-MS\/MS, HPLC-UV and immunoassay methods","volume":"44","author":"Sallustio","year":"2011","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.talanta.2023.124996_bib209","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jmsacl.2023.03.002","article-title":"Mass spectrometry quantitation of immunosuppressive drugs in clinical specimens using online solid-phase extraction and accurate-mass full scan-single ion monitoring","volume":"28","author":"Yeung","year":"2023","journal-title":"J. Mass Spectrom. Adv. Clin. Lab."},{"issue":"2","key":"10.1016\/j.talanta.2023.124996_bib210","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/FTD.0000000000000912","article-title":"Development and validation of A liquid chromatography-tandem mass spectrometry method to simultaneously measure tacrolimus and everolimus concentrations in kidney allograft biopsies after kidney transplantation","volume":"44","author":"Zhang","year":"2022","journal-title":"Ther. Drug Monit."},{"issue":"1","key":"10.1016\/j.talanta.2023.124996_bib211","doi-asserted-by":"crossref","DOI":"10.3390\/molecules28010248","article-title":"Simultaneous measurement of cortisol, cortisone, dexamethasone and additional Exogenous corticosteroids by rapid and sensitive LC-MS\/MS analysis","volume":"28","author":"Ponzetto","year":"2023","journal-title":"Molecules"},{"issue":"2","key":"10.1016\/j.talanta.2023.124996_bib212","first-page":"818","article-title":"Nirmatrelvir increases blood tacrolimus concentration in COVID-19 patients as determined by UHPLC-MS\/MS method","volume":"27","author":"Wu","year":"2023","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"10","key":"10.1016\/j.talanta.2023.124996_bib213","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1021\/jasms.2c00204","article-title":"A UPLC-MS\/MS method for plasma biological monitoring of Nirmatrelvir and Ritonavir in the context of SARS-CoV-2 infection and application to a case","volume":"33","author":"Guyon","year":"2022","journal-title":"J. Am. Soc. Mass Spectrom."},{"issue":"5","key":"10.1016\/j.talanta.2023.124996_bib45","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1007\/s10096-019-03769-8","article-title":"Diagnostic and medical needs for therapeutic drug monitoring of antibiotics","volume":"39","author":"Mabilat","year":"2020","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"issue":"1","key":"10.1016\/j.talanta.2023.124996_bib46","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/FTD.0000000000000940","article-title":"Therapeutic drug monitoring of antibiotics: defining the therapeutic range","volume":"44","author":"Abdul-Aziz","year":"2022","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.talanta.2023.124996_bib48","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.cca.2018.03.021","article-title":"Therapeutic drug monitoring of piperacillin and tazobactam by RP-HPLC of residual blood specimens","volume":"482","author":"Verhoven","year":"2018","journal-title":"Clin. Chim. Acta"},{"issue":"3","key":"10.1016\/j.talanta.2023.124996_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmi.2018.11.020","article-title":"Therapeutic drug monitoring of imipenem and the incidence of toxicity and failure in hospitalized patients: a retrospective cohort study","volume":"25","author":"Bricheux","year":"2019","journal-title":"Clin. Microbiol. Infection"},{"key":"10.1016\/j.talanta.2023.124996_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2020.113132","article-title":"A new validated HPLC-UV method for therapeutic monitoring of daptomycin in comparison with reference mass spectrometry","volume":"182","author":"Luci","year":"2020","journal-title":"J. Pharmaceut. Biomed. Anal."},{"issue":"5","key":"10.1016\/j.talanta.2023.124996_bib51","doi-asserted-by":"crossref","DOI":"10.1002\/bmc.4506","article-title":"Simultaneous quantification of levofloxacin, pefloxacin, ciprofloxacin and moxifloxacin in microvolumes of human plasma using high-performance liquid chromatography with ultraviolet detection","volume":"33","author":"Zheng","year":"2019","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.talanta.2023.124996_bib53","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.tube.2017.11.012","article-title":"Rapid and sensitive method for simultaneous determination of first-line anti-tuberculosis drugs in human plasma by HPLC-MS\/MS: application to therapeutic drug monitoring","volume":"109","author":"Gao","year":"2018","journal-title":"Tuberculosis"},{"issue":"9","key":"10.1016\/j.talanta.2023.124996_bib54","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1093\/jac\/dkv148","article-title":"A UPLC-MS-MS method for the simultaneous quantification of first-line antituberculars in plasma and in PBMCs","volume":"70","author":"Baietto","year":"2015","journal-title":"J. Antimicrob. Chemother."},{"issue":"12","key":"10.1016\/j.talanta.2023.124996_bib55","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1002\/bmc.3769","article-title":"Determination of chloramphenicol in biological matrices by solid-phase membrane micro-tip extraction and capillary electrophoresis","volume":"30","author":"Hussain","year":"2016","journal-title":"Biomed. Chromatogr."},{"issue":"4","key":"10.1016\/j.talanta.2023.124996_bib56","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1002\/elps.201700288","article-title":"Determination of tetracyclines in human urine samples by capillary electrophoresis in combination with field amplified sample injection","volume":"39","author":"Moreno-Gonzalez","year":"2018","journal-title":"Electrophoresis"},{"issue":"37","key":"10.1016\/j.talanta.2023.124996_bib57","doi-asserted-by":"crossref","first-page":"4307","DOI":"10.1039\/D1AY00711D","article-title":"Simultaneous determination of three antituberculosis drugs in the serum of patients with spinal tuberculosis by capillary electrophoresis","volume":"13","author":"Wu","year":"2021","journal-title":"Anal. Methods"},{"key":"10.1016\/j.talanta.2023.124996_bib58","article-title":"Determination of carbapenem antibiotics using a purpose-made capillary electrophoresis instrument with contactless conductivity detection","volume":"178","author":"Thi Ngoc Mai","year":"2020","journal-title":"J. Pharmaceut. Biomed. Anal."},{"issue":"1","key":"10.1016\/j.talanta.2023.124996_bib47","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/FTD.0000000000000942","article-title":"Therapeutic drug monitoring of antibiotics in critically ill patients: current practice and future perspectives with a focus on clinical outcome","volume":"44","author":"Koch","year":"2022","journal-title":"Ther. Drug Monit."},{"issue":"1","key":"10.1016\/j.talanta.2023.124996_bib59","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1089\/dia.2012.0188","article-title":"Use of microneedle array devices for continuous glucose monitoring: a review","volume":"15","author":"El-Laboudi","year":"2013","journal-title":"Diabetes Technol. Therapeut."},{"key":"10.1016\/j.talanta.2023.124996_bib60","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.coelec.2018.05.015","article-title":"Bio(inspired) strategies for the electro-sensing of beta-Iactam antibiotics","volume":"10","author":"Bottari","year":"2018","journal-title":"Curr. Opin. Electrochem."},{"issue":"7","key":"10.1016\/j.talanta.2023.124996_bib61","doi-asserted-by":"crossref","first-page":"E335","DOI":"10.1016\/S2589-7500(19)30131-1","article-title":"Microneedle biosensors for real-time, minimally invasive drug monitoring of phenoxymethylpenicillin: a first-in-human evaluation in healthy volunteers","volume":"1","author":"Rawson","year":"2019","journal-title":"Lancet Digit. Health"},{"issue":"4","key":"10.1016\/j.talanta.2023.124996_bib62","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1093\/jac\/dkx458","article-title":"Delivering precision antimicrobial therapy through closed-loop control systems","volume":"73","author":"Rawson","year":"2018","journal-title":"J. Antimicrob. Chemother."},{"issue":"10","key":"10.1016\/j.talanta.2023.124996_bib214","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1002\/jssc.202200064","article-title":"A sensitive and selective HPLC-MS3 method for therapeutic drug monitoring of meropenem and its validation by comparison with HPLC-MS2 methods","volume":"45","author":"Cao","year":"2022","journal-title":"J. Separ. Sci."},{"issue":"6","key":"10.1016\/j.talanta.2023.124996_bib215","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27061991","article-title":"Dried plasma spot based LC-MS\/MS method for monitoring of meropenem in the blood of treated patients","volume":"27","author":"Cao","year":"2022","journal-title":"Molecules"},{"issue":"4","key":"10.1016\/j.talanta.2023.124996_bib216","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1248\/bpb.b21-00798","article-title":"Development of a method of liquid chromatography coupled with tandem mass spectrometry for simultaneous determination of linezolid and Tedizolid in human plasma","volume":"45","author":"Sato","year":"2022","journal-title":"Biol. Pharm. Bull."},{"issue":"5","key":"10.1016\/j.talanta.2023.124996_bib217","article-title":"Validation and application of an HPLC-UV method for routine therapeutic drug monitoring of dalbavancin","volume":"11","author":"Chiriac","year":"2022","journal-title":"Antibiot. Basel"},{"issue":"2","key":"10.1016\/j.talanta.2023.124996_bib218","article-title":"A validated UHPLC-MS\/MS method to quantify eight antibiotics in quantitative dried blood spots in support of pharmacokinetic studies in Neonates","volume":"12","author":"Liu","year":"2023","journal-title":"Antibiot. Basel"},{"issue":"2","key":"10.1016\/j.talanta.2023.124996_bib219","doi-asserted-by":"crossref","DOI":"10.3390\/ph15020112","article-title":"Application of optical methods for determination of concentration of doxorubicin in blood and plasma","volume":"15","author":"Sikora","year":"2022","journal-title":"Pharmaceuticals"},{"issue":"11","key":"10.1016\/j.talanta.2023.124996_bib168","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/j.cmi.2020.05.037","article-title":"Antifungal therapeutic drug monitoring: focus on drugs without a clear recommendation","volume":"26","author":"Gomez-Lopez","year":"2020","journal-title":"Clin. Microbiol. Infection"},{"issue":"11","key":"10.1016\/j.talanta.2023.124996_bib167","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1080\/17425255.2019.1671971","article-title":"Therapeutic drug monitoring of systemic antifungal agents: a pragmatic approach for adult and pediatric patients","volume":"15","author":"John","year":"2019","journal-title":"Expet Opin. Drug Metabol. Toxicol."},{"issue":"4","key":"10.1016\/j.talanta.2023.124996_bib170","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1080\/10408347.2020.1726726","article-title":"Biological properties and analytical methods for micafungin: a critical review","volume":"51","author":"Marena","year":"2021","journal-title":"Crit. Rev. Anal. Chem."},{"issue":"4","key":"10.1016\/j.talanta.2023.124996_bib169","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1097\/QCO.0000000000000740","article-title":"Managing uncertainty in antifungal dosing: antibiograms, therapeutic drug monitoring and drug-drug interactions","volume":"34","author":"Lewis","year":"2021","journal-title":"Curr. Opin. Infect. Dis."},{"issue":"1","key":"10.1016\/j.talanta.2023.124996_bib176","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/FTD.0000000000000952","article-title":"Antifungal drugs TDM: trends and update","volume":"44","author":"Kably","year":"2022","journal-title":"Ther. Drug Monit."},{"issue":"2","key":"10.1016\/j.talanta.2023.124996_bib63","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/fcp.12507","article-title":"Refining the therapeutic range of posaconazole and isavuconazole for efficient therapeutic drug monitoring using a bioassay approach","volume":"34","author":"Willeman","year":"2020","journal-title":"Fund. Clin. Pharmacol."},{"key":"10.1016\/j.talanta.2023.124996_bib64","article-title":"Optimization of the therapeutic range for therapeutic drug monitoring of posaconazole and isavuconazole using a bioassay approach","volume":"33","author":"Willeman","year":"2019","journal-title":"Fundam. Clin. Pharmacol."},{"issue":"1","key":"10.1016\/j.talanta.2023.124996_bib65","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.diagmicrobio.2018.04.003","article-title":"Simultaneous quantification of systemic azoles and their major metabolites in human serum by HPLC\/PDA: role of azole metabolic rate","volume":"92","author":"Gomez-Lopez","year":"2018","journal-title":"Diagn. Microbiol. Infect. Dis."},{"issue":"1","key":"10.1016\/j.talanta.2023.124996_bib66","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s11046-020-00514-0","article-title":"Rapid and simple reversed-phase high-performance liquid chromatography (RP-HPLC) method for simultaneous quantifications of triazole antifungals in human serum","volume":"186","author":"Choudhary","year":"2021","journal-title":"Mycopathologia"},{"key":"10.1016\/j.talanta.2023.124996_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2019.112952","article-title":"Determination of total and free voriconazole in human plasma: application to pharmacokinetic study and therapeutic monitoring","volume":"178","author":"Resztak","year":"2020","journal-title":"J. Pharmaceut. Biomed. Anal."},{"key":"10.1016\/j.talanta.2023.124996_bib68","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.clinbiochem.2018.01.004","article-title":"Simultaneous determination of voriconazole, posaconazole, itraconazole and hydroxy-itraconazole in human plasma using LCMS\/MS","volume":"53","author":"Jenkins","year":"2018","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.talanta.2023.124996_bib69","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.jpba.2017.07.040","article-title":"A simple high performance liquid chromatography-mass spectrometry method for Therapeutic Drug Monitoring of isavuconazole and four other antifungal drugs in human plasma samples","volume":"145","author":"Fatiguso","year":"2017","journal-title":"J. Pharmaceut. Biomed. Anal."},{"key":"10.1016\/j.talanta.2023.124996_bib70","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jchromb.2017.01.036","article-title":"An ultra performance liquid chromatography-tandem mass spectrometry method for the therapeutic drug monitoring of isavuconazole and seven other antifungal compounds in plasma samples","volume":"1046","author":"Toussaint","year":"2017","journal-title":"J. Chromatogr., B: Anal. Technol. Biomed. Life Sci."},{"issue":"11","key":"10.1016\/j.talanta.2023.124996_bib71","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1111\/1440-1681.12822","article-title":"Pharmacokinetic evaluation of oral itraconazole for antifungal prophylaxis in children","volume":"44","author":"Allegra","year":"2017","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"issue":"11","key":"10.1016\/j.talanta.2023.124996_bib72","doi-asserted-by":"crossref","first-page":"877","DOI":"10.4155\/bio-2017-0275","article-title":"Simple and robust LC-MS\/MS analysis method for therapeutic drug monitoring of micafungin","volume":"10","author":"Boonstra","year":"2018","journal-title":"Bioanalysis"},{"issue":"6","key":"10.1016\/j.talanta.2023.124996_bib73","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1373\/jalm.2016.022756","article-title":"A rapid high-performance LC-MS\/MS method for therapeutic drug monitoring of voriconazole, posaconazole, fluconazole, and itraconazole in human serum","volume":"1","author":"Xiao","year":"2017","journal-title":"J. Appl. Lab. Med."},{"issue":"18","key":"10.1016\/j.talanta.2023.124996_bib74","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/j.clinbiochem.2017.09.011","article-title":"Sensitive and selective quantification of total and free itraconazole and hydroxyitraconazole in human plasma using ultra-performance liquid chromatography coupled to tandem mass spectrometry","volume":"50","author":"Suzuki","year":"2017","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.talanta.2023.124996_bib75","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.cca.2018.07.022","article-title":"A rapid ultra-performance LC-MS\/MS assay for determination of serum unbound fraction of voriconazole in cancer patients","volume":"486","author":"Li","year":"2018","journal-title":"Clin. Chim. Acta"},{"issue":"5","key":"10.1016\/j.talanta.2023.124996_bib76","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1097\/FTD.0000000000000438","article-title":"Reliable and easy-to-use liquid chromatography-tandem mass spectrometry method for simultaneous analysis of fluconazole, isavuconazole, itraconazole, hydroxy-itraconazole, posaconazole, and voriconazole in human plasma and serum","volume":"39","author":"Mueller","year":"2017","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.talanta.2023.124996_bib77","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.cca.2017.08.032","article-title":"Development and validation of a liquid chromatography-tandem mass spectrometry assay for the simultaneous quantitation of 5 azole antifungals and 1 active metabolite","volume":"474","author":"McShane","year":"2017","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.talanta.2023.124996_bib78","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.talanta.2016.12.052","article-title":"Utilizing online-dual-SPE-LC with HRMS for the simultaneous quantification of amphotericin B, fluconazole, and fluorocytosine in human plasma and cerebrospinal fluid","volume":"165","author":"Qu","year":"2017","journal-title":"Talanta"},{"key":"10.1016\/j.talanta.2023.124996_bib194","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2019.121937","article-title":"Quantification of anidulafungin and micafungin in human body fluids by high performance-liquid chromatography with UV-detection","volume":"1139","author":"Welte","year":"2020","journal-title":"J. Chromatogr., B: Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.talanta.2023.124996_bib79","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2022.114875","article-title":"Development and application of amphotericin B immunoassay for pharmacokinetic studies and therapeutic drug monitoring in critically ill patients","volume":"218","author":"Burkin","year":"2022","journal-title":"J. Pharmaceut. Biomed. Anal."},{"issue":"3","key":"10.1016\/j.talanta.2023.124996_bib80","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1136\/ejhpharm-2019-002155","article-title":"Therapeutic drug monitoring of voriconazole: validation of a high performance liquid chromatography method and comparison with an ARK immunoassay","volume":"28","author":"Blanco-Dorado","year":"2021","journal-title":"Eur. J. Hosp. Pharm."},{"issue":"6","key":"10.1016\/j.talanta.2023.124996_bib81","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1177\/00045632211041887","article-title":"Comparison of ultra-performance liquid chromatography and ARK immunoassay for therapeutic drug monitoring of voriconazole","volume":"58","author":"Pena-Lorenzo","year":"2021","journal-title":"Ann. Clin. Biochem."},{"issue":"2","key":"10.1016\/j.talanta.2023.124996_bib82","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1080\/00365513.2020.1868048","article-title":"Correlation between enzyme multiplied immunoassay technique and high-performance liquid chromatography in the quantification of voriconazole in a paediatric population","volume":"81","author":"Li","year":"2021","journal-title":"Scand. J. Clin. Lab. Invest."},{"key":"10.1016\/j.talanta.2023.124996_bib220","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2022.114659","article-title":"Simultaneous determination of linezolid and voriconazole serum concentrations using liquid chromatography-tandem mass spectrometry","volume":"212","author":"Lu","year":"2022","journal-title":"J. Pharmaceut. Biomed. Anal."},{"key":"10.1016\/j.talanta.2023.124996_bib221","doi-asserted-by":"crossref","DOI":"10.1016\/j.ab.2022.114951","article-title":"Rapid back flushed direct sample injection bio-analytical HPLC-UV method for therapeutic drug monitoring of terbinafine","volume":"659","author":"El-Gendy","year":"2022","journal-title":"Anal. Biochem."},{"issue":"6","key":"10.1016\/j.talanta.2023.124996_bib222","doi-asserted-by":"crossref","DOI":"10.1002\/bmc.5356","article-title":"UPLC-MS\/MS method for the determination of voriconazole plasma concentration from pediatric patients with hematologic tumors: an application toward personalized therapy","volume":"36","author":"Wen","year":"2022","journal-title":"Biomed. Chromatogr."},{"issue":"1","key":"10.1016\/j.talanta.2023.124996_bib160","first-page":"8","article-title":"\"The black book of psychotropic dosing and monitoring.\"","volume":"51","author":"DeBattista","year":"2021","journal-title":"Psychopharmacol. Bull."},{"key":"10.1016\/j.talanta.2023.124996_bib161","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2021.787043","article-title":"\"Therapeutic reference ranges for psychotropic drugs: a protocol for systematic reviews.\"","volume":"12","author":"Hart","year":"2021","journal-title":"Front. Psychiatr."},{"key":"10.1016\/j.talanta.2023.124996_bib162","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.trac.2016.05.027","article-title":"\"Therapeutic Drug Monitoring for individualised risk reduction in psychopharmacotherapy.\"","volume":"84","author":"Schuetze","year":"2016","journal-title":"Trac. Trends Anal. Chem."},{"issue":"1","key":"10.1016\/j.talanta.2023.124996_bib164","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1055\/a-1288-1061","article-title":"Review and consensus on pharmacogenomic testing in psychiatry","volume":"54","author":"Bousman","year":"2021","journal-title":"Pharmacopsychiatry"},{"issue":"6","key":"10.1016\/j.talanta.2023.124996_bib165","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1093\/chromsci\/bmy024","article-title":"Simultaneous determination of antipsychotic drugs and their active metabolites by LC-MS-MS and its application to therapeutic drug monitoring","volume":"56","author":"Miroshnichenko","year":"2018","journal-title":"J. Chromatogr. Sci."},{"issue":"10","key":"10.1016\/j.talanta.2023.124996_bib83","article-title":"Development and validation of an HPLC-UV method for the simultaneous determination of the antipsychotics clozapine, olanzapine and quetiapine, several beta-blockers and their metabolites","volume":"31","author":"Gracia","year":"2017","journal-title":"Biomed. Chromatogr."},{"issue":"10","key":"10.1016\/j.talanta.2023.124996_bib84","doi-asserted-by":"crossref","DOI":"10.1002\/bmc.4609","article-title":"Determination of hydroxybupropion in human serum for routine therapeutic drug monitoring in psychiatry: a tool for dose-individualization in treatment with bupropion","volume":"33","author":"Scherf-Clavel","year":"2019","journal-title":"Biomed. Chromatogr."},{"issue":"1","key":"10.1016\/j.talanta.2023.124996_bib85","doi-asserted-by":"crossref","DOI":"10.1002\/bmc.4398","article-title":"Optimization and validation of an SBSE-HPLC-FD method using laboratory-made stir bars for fluoxetine determination in human plasma","volume":"33","author":"Marques","year":"2019","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.talanta.2023.124996_bib86","doi-asserted-by":"crossref","DOI":"10.1016\/j.microc.2020.104606","article-title":"The use of micro carbon pencil lead electrode for sensitive HPLC-ED analysis of selected antipsychotic drugs","volume":"154","author":"Riman","year":"2020","journal-title":"Microchem. J."},{"issue":"9","key":"10.1016\/j.talanta.2023.124996_bib87","doi-asserted-by":"crossref","DOI":"10.1002\/bmc.3950","article-title":"Development and validation of a reversed-phase HPLC method for licarbazepine monitoring in serum of patients under oxcarbazepine treatment","volume":"31","author":"Begas","year":"2017","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.talanta.2023.124996_bib88","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.cca.2018.06.047","article-title":"Validation of a simple, fast liquid chromatography-tandem mass spectrometry method for the simultaneous quantification of 40 antidepressant drugs or their metabolites in plasma","volume":"485","author":"Degreef","year":"2018","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.talanta.2023.124996_bib89","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.clinms.2019.05.004","article-title":"A semi-automated, isotope-dilution high-resolution mass spectrometry assay for therapeutic drug monitoring of antidepressants","volume":"14","author":"Lindner","year":"2019","journal-title":"Clin. Mass Spectrom."},{"key":"10.1016\/j.talanta.2023.124996_bib90","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jad.2017.01.019","article-title":"Sertraline in pregnancy - therapeutic drug monitoring in maternal blood, amniotic fluid and cord blood","volume":"212","author":"Paulzen","year":"2017","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.talanta.2023.124996_bib91","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.jpba.2017.02.061","article-title":"Validation of a dried blood spot method for therapeutic drug monitoring of citalopram, mirtazapine and risperidone and its active metabolite 9- hydroxyrisperidone using HPLC-MS","volume":"140","author":"Weber","year":"2017","journal-title":"J. Pharmaceut. Biomed. Anal."},{"issue":"264","key":"10.1016\/j.talanta.2023.124996_bib92","first-page":"109","article-title":"Development of the G C -M S\/M S method for qualitative and quantitative determination of clozapine in human blood","author":"Sivsivadze","year":"2017","journal-title":"Georgian Med. News"},{"issue":"23","key":"10.1016\/j.talanta.2023.124996_bib93","doi-asserted-by":"crossref","first-page":"6141","DOI":"10.1007\/s00216-019-02005-8","article-title":"Determination of antipsychotic drugs in oral fluid using dried saliva spots by gas chromatography-tandem mass spectrometry","volume":"411","author":"Caramelo","year":"2019","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.talanta.2023.124996_bib94","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jpba.2017.04.032","article-title":"Ultrasound-assisted low-density solvent dispersive liquid-liquid microextraction for the simultaneous determination of 12 new antidepressants and 2 antipsychotics in whole blood by gas chromatography-mass spectrometry","volume":"142","author":"Chen","year":"2017","journal-title":"J. Pharmaceut. Biomed. Anal."},{"issue":"1","key":"10.1016\/j.talanta.2023.124996_bib95","first-page":"110","article-title":"Determination of haloperidol drug in ampoules and in urine samples using a potentiometric PVC-membrane and graphite coated wire electrodes","volume":"21","author":"Shawish","year":"2017","journal-title":"Marmara Pharm. J."},{"key":"10.1016\/j.talanta.2023.124996_bib96","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.snb.2017.03.102","article-title":"An electrochemical sensor for clozapine at ruthenium doped TiO2 nanoparticles modified electrode","volume":"247","author":"Shetti","year":"2017","journal-title":"Sensor. Actuator. B Chem."},{"issue":"11","key":"10.1016\/j.talanta.2023.124996_bib97","doi-asserted-by":"crossref","DOI":"10.1007\/s00604-019-3760-7","article-title":"Electrochemical determination of the antipsychotic medication clozapine by a carbon paste electrode modified with a nanostructure prepared from titania nanoparticles and copper oxide","volume":"186","author":"Ghanbari","year":"2019","journal-title":"Microchim. Acta"},{"issue":"5","key":"10.1016\/j.talanta.2023.124996_bib98","doi-asserted-by":"crossref","first-page":"3709","DOI":"10.20964\/2017.05.34","article-title":"Novel strategy for electroanalytical detection of antipsychotic drugs chlorpromazine and thioridazine; possibilities for simultaneous determination","volume":"12","author":"Petkovic","year":"2017","journal-title":"Int. J. Electrochem. Sci."},{"key":"10.1016\/j.talanta.2023.124996_bib99","series-title":"International Conference on Smart Engineering Materials","article-title":"An enhanced sensing platform for clozapine at 2.0% silver doped TiO2 nanoparticles - a sensitive detection","author":"Shetti","year":"2016"},{"issue":"18","key":"10.1016\/j.talanta.2023.124996_bib100","doi-asserted-by":"crossref","DOI":"10.1002\/jssc.201800417","article-title":"Electrochemically controlled fiber-in-tube solid-phase microextraction method for the determination of trace amounts of antipsychotic drugs in biological samples","volume":"41","author":"Shamsayei","year":"2018","journal-title":"J. Separ. Sci."},{"issue":"12","key":"10.1016\/j.talanta.2023.124996_bib101","doi-asserted-by":"crossref","first-page":"4295","DOI":"10.1039\/D0AN00846J","article-title":"Electrochemiluminescent sensors as a screening strategy for psychoactive substances within biological matrices","volume":"145","author":"Brown","year":"2020","journal-title":"Analyst"},{"issue":"4","key":"10.1016\/j.talanta.2023.124996_bib102","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/dta.2520","article-title":"Development of a fluvoxamine detection system using a Quenchbody, a novel fluorescent biosensor","volume":"11","author":"Sasao","year":"2019","journal-title":"Drug Test. Anal."},{"issue":"11","key":"10.1016\/j.talanta.2023.124996_bib103","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1002\/rcm.8112","article-title":"Low-temperature plasma-probe mass spectrometry based method for determination of new psychoactive substances in oral fluid","volume":"32","author":"Wang","year":"2018","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"10.1016\/j.talanta.2023.124996_bib166","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.cca.2020.05.025","article-title":"Bioassay: a novel approach in antipsychotic pharmacology","volume":"509","author":"Mobed","year":"2020","journal-title":"Clin. Chim. Acta"},{"issue":"5","key":"10.1016\/j.talanta.2023.124996_bib104","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1097\/FTD.0000000000000777","article-title":"Comparison of novel immunoassay with liquid chromatography\/tandem mass spectrometry (LC-MS\/MS) for therapeutic drug monitoring of clozapine","volume":"42","author":"Buckley","year":"2020","journal-title":"Ther. Drug Monit."},{"issue":"60","key":"10.1016\/j.talanta.2023.124996_bib105","doi-asserted-by":"crossref","first-page":"36609","DOI":"10.1039\/D0RA06839J","article-title":"A novel surface-enhanced Raman scattering method for simultaneous detection of ketamine and amphetamine","volume":"10","author":"Sun","year":"2020","journal-title":"RSC Adv."},{"issue":"1","key":"10.1016\/j.talanta.2023.124996_bib106","article-title":"Evaluation of CEDIA and DRI drugs of abuse immunoassays for urine screening on a Thermo Indiko Plus analyzer","volume":"31","author":"Koehler","year":"2017","journal-title":"J. Clin. Lab. Anal."},{"issue":"1","key":"10.1016\/j.talanta.2023.124996_bib193","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1515\/chem-2019-0152","article-title":"Optimization of chromatographic systems for analysis of selected psychotropic drugs and their metabolites in serum and saliva by HPLC in order to monitor therapeutic drugs","volume":"17","author":"Wroblewski","year":"2019","journal-title":"Open Chem."},{"key":"10.1016\/j.talanta.2023.124996_bib223","doi-asserted-by":"crossref","DOI":"10.1016\/j.cca.2023.117322","article-title":"A novel method for the therapeutic drug monitoring of biperiden in plasma by GC-MS using salt-assisted liquid-liquid microextraction","volume":"543","author":"Kul","year":"2023","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.talanta.2023.124996_bib224","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2022.114591","article-title":"Determination of clozapine and norclozapine in dried plasma spot and dried blood spot by liquid chromatography-tandem mass spectrometry","volume":"210","author":"Carniel","year":"2022","journal-title":"J. Pharmaceut. Biomed. Anal."},{"key":"10.1016\/j.talanta.2023.124996_bib225","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2022.114617","article-title":"A selective and accurate liquid chromatography-tandem mass spectrometry method for the quantitation of the novel 5-HT4 receptor partial agonist SUVN-D4010 (Usmarapride) in human plasma and urine","volume":"211","author":"Nirogi","year":"2022","journal-title":"J. Pharmaceut. Biomed. Anal."},{"key":"10.1016\/j.talanta.2023.124996_bib226","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2022.123534","article-title":"Liquid chromatography-tandem mass spectrometry method for the bioanalysis of N,N-dimethyltryptamine (DMT) and its metabolites DMT-N-oxide and indole-3-acetic acid in human plasma","volume":"1213","author":"Luethi","year":"2022","journal-title":"J. Chromatogr., B: Anal. Technol. Biomed. Life Sci."},{"issue":"3","key":"10.1016\/j.talanta.2023.124996_bib227","article-title":"Electrochemistry test strip as platform for in situ detection of blood levels of antipsychotic clozapine in finger-pricked sample volume","volume":"13","author":"Senel","year":"2023","journal-title":"Biosens. Bioelectron."},{"issue":"1","key":"10.1016\/j.talanta.2023.124996_bib228","doi-asserted-by":"crossref","DOI":"10.1186\/s13065-022-00894-y","article-title":"Nitrogen and sulfur-doped carbon quantum dots as fluorescent nanoprobes for spectrofluorimetric determination of olanzapine and diazepam in biological fluids and dosage forms: application to content uniformity testing","volume":"16","author":"Magdy","year":"2022","journal-title":"Bmc Chem."},{"issue":"4","key":"10.1016\/j.talanta.2023.124996_bib158","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1253\/circj.CJ-66-0138","article-title":"\"Guidelines for therapeutic drug monitoring of cardiovascular drugs clinical use of blood drug concentration monitoring (JCS 2015) - digest version.\"","volume":"81","author":"Aonuma","year":"2017","journal-title":"Circ. J."},{"issue":"2","key":"10.1016\/j.talanta.2023.124996_bib107","doi-asserted-by":"crossref","DOI":"10.1002\/bmc.4099","article-title":"Simultaneous determination of serum propafenone and its metabolites using high-performance liquid chromatography","volume":"32","author":"Shirayama","year":"2018","journal-title":"Biomed. Chromatogr."},{"issue":"23","key":"10.1016\/j.talanta.2023.124996_bib108","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.4155\/bio-2019-0083","article-title":"Analytical techniques for the determination of verapamil in biological samples and dosage forms: an overview","volume":"11","author":"Pourkarim","year":"2019","journal-title":"Bioanalysis"},{"key":"10.1016\/j.talanta.2023.124996_bib109","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.109813","article-title":"Digoxin as a glycosylated steroid-like therapeutic drug: recent advances in the clinical pharmacology and bioassays of pharmaceutical compounds","volume":"123","author":"Pashazadeh-Panahi","year":"2020","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.talanta.2023.124996_bib110","doi-asserted-by":"crossref","DOI":"10.3390\/scipharm86010001","article-title":"A fast and validated reversed-phase HPLC method for simultaneous determination of simvastatin, atorvastatin, telmisartan and irbesartan in bulk drugs and tablet formulations","volume":"86","author":"Alhazmi","year":"2017","journal-title":"Sci. Pharm."},{"issue":"11","key":"10.1016\/j.talanta.2023.124996_bib111","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1007\/s11094-019-01933-0","article-title":"Dad based stability indicating RP-UPLC method for simultaneous determination of olmesartan MEDOXOMIL and amlodipine besylate","volume":"52","author":"Kerai","year":"2019","journal-title":"Pharmaceut. Chem. J."},{"key":"10.1016\/j.talanta.2023.124996_bib112","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.jpba.2018.02.030","article-title":"Validated determination of losartan and valsartan in human plasma by stir bar sorptive extraction based on acrylate monolithic polymer, liquid chromatographic analysis and experimental design methodology","volume":"153","author":"Babarahimi","year":"2018","journal-title":"J. Pharmaceut. Biomed. Anal."},{"issue":"4","key":"10.1016\/j.talanta.2023.124996_bib113","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s10337-022-04141-3","article-title":"Simultaneous Enantioseparation and rapid determination of atenolol and amlodipine besylate by capillary electrochromatography","volume":"85","author":"Gao","year":"2022","journal-title":"Chromatographia"},{"key":"10.1016\/j.talanta.2023.124996_bib114","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.cca.2017.01.027","article-title":"Milrinone therapeutic drug monitoring in a pediatric population: development and validation of a quantitative liquid chromatography-tandem mass spectrometry method","volume":"468","author":"Raizman","year":"2017","journal-title":"Clin. Chim. Acta"},{"issue":"12","key":"10.1016\/j.talanta.2023.124996_bib115","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1007\/s11094-018-1750-4","article-title":"Simultaneous determination of metoprolol and bisoprolol in human serum by HPLC-MS\/MS for clinical drug monitoring","volume":"51","author":"Rodina","year":"2018","journal-title":"Pharmaceut. Chem. J."},{"issue":"4","key":"10.1016\/j.talanta.2023.124996_bib116","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.jfda.2019.06.001","article-title":"Simultaneous determination of cardiovascular drugs in dried blood spot by liquid chromatography-tandem mass spectrometry","volume":"27","author":"Kim","year":"2019","journal-title":"J. Food Drug Anal."},{"key":"10.1016\/j.talanta.2023.124996_bib117","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.jpba.2017.04.045","article-title":"Quantitative LC-HRMS determination of selected cardiovascular drugs, in dried blood spots, as an indicator of adherence to medication","volume":"142","author":"Bernieh","year":"2017","journal-title":"J. Pharmaceut. Biomed. Anal."},{"issue":"10","key":"10.1016\/j.talanta.2023.124996_bib118","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1093\/chromsci\/bmy055","article-title":"Challenges in simultaneous determination of hydrochlorothiazide and ramipril in human plasma: application to a bioequivalence study","volume":"56","author":"Patel","year":"2018","journal-title":"J. Chromatogr. Sci."},{"issue":"9","key":"10.1016\/j.talanta.2023.124996_bib119","doi-asserted-by":"crossref","first-page":"569","DOI":"10.4155\/bio-2020-0037","article-title":"Simultaneous determination of canrenone, digoxin and tolvaptan by UHPLC-MS\/MS: application in heart failure patients","volume":"12","author":"Guo","year":"2020","journal-title":"Bioanalysis"},{"issue":"6","key":"10.1016\/j.talanta.2023.124996_bib120","doi-asserted-by":"crossref","DOI":"10.1149\/1945-7111\/ac76e2","article-title":"Advanced sensing performance towards simultaneous determination of binary mixture of antihypertensives using PANI-cerium oxide nanoparticles as modifier in carbon paste incorporating graphite and silicone-oil","volume":"169","author":"Sharma","year":"2022","journal-title":"J. Electrochem. Soc."},{"key":"10.1016\/j.talanta.2023.124996_bib121","series-title":"Electrochemical Sensing Platform Based on Graphene Oxide -chitosan for Simultaneous Determination of Some Antihypertensive Drugs","author":"Nabizadeh","year":"2022"},{"key":"10.1016\/j.talanta.2023.124996_bib122","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/9065249","article-title":"A localized surface plasmon resonance sensing method for simultaneous determination of atenolol and amiloride in pharmaceutical dosage forms and urine samples","volume":"2018","author":"El-Zahry","year":"2018","journal-title":"J. Anal. Methods Chem."},{"key":"10.1016\/j.talanta.2023.124996_bib123","doi-asserted-by":"crossref","DOI":"10.1016\/j.saa.2020.119345","article-title":"An ultra-sensitive optical aptasensor based on gold nanoparticles\/poly vinyl alcohol hydrogel as acceptor\/emitter pair for fluorometric detection of digoxin with on\/off\/on strategy","volume":"250","author":"Shirani","year":"2021","journal-title":"Spectrochim. Acta Mol. Biomol. Spectrosc."},{"issue":"5","key":"10.1016\/j.talanta.2023.124996_bib124","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.1039\/D1RA07680A","article-title":"Electrochemically driven optical and SERS immunosensor for the detection of a therapeutic cardiac drug","volume":"12","author":"Chaudhry","year":"2022","journal-title":"RSC Adv."},{"issue":"2","key":"10.1016\/j.talanta.2023.124996_bib125","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1080\/00015385.2021.1903195","article-title":"Performances of a novel chemiluninescence ABEI-based NT-proBNP immunoassay","volume":"77","author":"Adamantidou","year":"2022","journal-title":"Acta Cardiol."},{"issue":"6","key":"10.1016\/j.talanta.2023.124996_bib126","doi-asserted-by":"crossref","DOI":"10.1002\/advs.201802051","article-title":"Quantitative detection of digoxin in plasma using small-molecule immunoassay in a recyclable gravity-driven microfluidic chip","volume":"6","author":"Li","year":"2019","journal-title":"Adv. Sci."},{"key":"10.1016\/j.talanta.2023.124996_bib229","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2022.123552","article-title":"Development and validation of an analytical method using liquid chromatography-tandem mass spectrometry for the therapeutic drug monitoring of seven cardiovascular drugs in clinical usage","volume":"1214","author":"Abady","year":"2023","journal-title":"J. Chromatogr., B: Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.talanta.2023.124996_bib230","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2023.123681","article-title":"A simple and sensitive LC-MS\/MS method for therapeutic drug monitoring of digoxin in children","volume":"1221","author":"Yang","year":"2023","journal-title":"J. Chromatogr., B: Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.talanta.2023.124996_bib231","doi-asserted-by":"crossref","DOI":"10.1016\/j.microc.2023.108422","article-title":"Carbon microspheres uniformly decorated with ceria nanoparticles as an ultrasensitive platform for electrochemical sensing of antihypertensive drug lacidipine in patient plasma and pharmaceutical formulation","volume":"187","author":"Mohamed","year":"2023","journal-title":"Microchem. J."},{"issue":"3","key":"10.1016\/j.talanta.2023.124996_bib154","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1177\/1078155220979048","article-title":"Applications and challenges in therapeutic drug monitoring of cancer treatment: a review","volume":"27","author":"Salman","year":"2021","journal-title":"J. Oncol. Pharm. Pract."},{"issue":"2","key":"10.1016\/j.talanta.2023.124996_bib155","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/bcp.14372","article-title":"Barriers and opportunities for the clinical implementation of therapeutic drug monitoring in oncology","volume":"87","author":"Menz","year":"2021","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"1","key":"10.1016\/j.talanta.2023.124996_bib156","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/FTD.0000000000000573","article-title":"New mass spectrometric approaches for the quantitative evaluation of anticancer drug levels in treated patients","volume":"41","author":"D'Aronco","year":"2019","journal-title":"Ther. Drug Monit."},{"issue":"2","key":"10.1016\/j.talanta.2023.124996_bib157","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1254\/fpj.153.73","article-title":"\"Personalized medicine for oral molecular-targeted anticancer drugs.\" Nihon yakurigaku zasshi","volume":"153","author":"Miura","year":"2019","journal-title":"Folia Pharmacol. Jpn."},{"key":"10.1016\/j.talanta.2023.124996_bib127","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.leukres.2017.11.012","article-title":"Therapeutic drug monitoring of ponatinib using a simple high-performance liquid chromatography method in Japanese patients","volume":"64","author":"Abumiya","year":"2018","journal-title":"Leuk. Res."},{"issue":"2","key":"10.1016\/j.talanta.2023.124996_bib139","doi-asserted-by":"crossref","DOI":"10.3390\/ph14020104","article-title":"The protein-binding behavior of platinum anticancer drugs in blood revealed by mass spectrometry","volume":"14","author":"Wang","year":"2021","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.talanta.2023.124996_bib140","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jpba.2018.06.032","article-title":"Practical fluorimetric assay for the detection of anticancer drug SN-38 in human plasma","volume":"159","author":"Tartaggia","year":"2018","journal-title":"J. Pharmaceut. Biomed. Anal."},{"issue":"5","key":"10.1016\/j.talanta.2023.124996_bib141","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1039\/C8AY02286K","article-title":"A microscale spectrophotometric method for quantification of doxorubicin in exhaled breath condensate","volume":"11","author":"Jouyban","year":"2019","journal-title":"Anal. Methods"},{"key":"10.1016\/j.talanta.2023.124996_bib142","doi-asserted-by":"crossref","DOI":"10.1016\/j.saa.2021.119987","article-title":"Simple and efficient spectroscopic-based univariate sequential methods for simultaneous quantitative analysis of vandetanib, dasatinib, and sorafenib in pharmaceutical preparations and biological fluids","volume":"260","author":"Abdelhameed","year":"2021","journal-title":"Spectrochim. Acta Mol. Biomol. Spectrosc."},{"key":"10.1016\/j.talanta.2023.124996_bib143","doi-asserted-by":"crossref","DOI":"10.1016\/j.bios.2019.111947","article-title":"Nitrogen-doped carbon quantum dots embedded Co3O4 with multiwall carbon nanotubes: an efficient probe for the simultaneous determination of anticancer and antibiotic drugs","volume":"150","author":"Muthusankar","year":"2020","journal-title":"Biosens. Bioelectron."},{"issue":"5","key":"10.1016\/j.talanta.2023.124996_bib144","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23052429","article-title":"Application of a screen-printed sensor modified with carbon nanofibers for the voltammetric analysis of an anticancer disubstituted fused Triazinone","volume":"23","author":"Kozak","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.talanta.2023.124996_bib145","doi-asserted-by":"crossref","DOI":"10.1016\/j.molliq.2021.115768","article-title":"Synthesis of nitrogen-doped carbon quantum dots@Fe2O3\/multiwall carbon nanotubes ternary nanocomposite for the simultaneous electrochemical detection of 5-fluorouracil, uric acid, and xanthine","volume":"331","author":"Ganesan","year":"2021","journal-title":"J. Mol. Liq."},{"key":"10.1016\/j.talanta.2023.124996_bib128","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2019.121910","article-title":"Development and validation of a high-performance liquid chromatographic method with a fluorescence detector for the analysis of epirubicin in human urine and plasma, and its application in drug monitoring","volume":"1136","author":"Treder","year":"2020","journal-title":"J. Chromatogr., B: Anal. Technol. Biomed. Life Sci."},{"issue":"9","key":"10.1016\/j.talanta.2023.124996_bib129","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1093\/chromsci\/bmy053","article-title":"Optimization of a precolumn OPA derivatization HPLC assay for monitoring of L-asparagine depletion in serum during L-Asparaginase therapy","volume":"56","author":"Zhang","year":"2018","journal-title":"J. Chromatogr. Sci."},{"issue":"3","key":"10.1016\/j.talanta.2023.124996_bib130","doi-asserted-by":"crossref","DOI":"10.1002\/bmc.4435","article-title":"Simple determination of plasma ibrutinib concentration using high-performance liquid chromatography","volume":"33","author":"Yasu","year":"2019","journal-title":"Biomed. Chromatogr."},{"issue":"11","key":"10.1016\/j.talanta.2023.124996_bib131","doi-asserted-by":"crossref","DOI":"10.1002\/bmc.3993","article-title":"Therapeutic drug monitoring of mitotane: analytical assay and patient follow-up","volume":"31","author":"Feliu","year":"2017","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.talanta.2023.124996_bib132","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jchromb.2017.09.008","article-title":"Determination of hydroxyurea in human plasma by HPLC-UV using derivatization with xanthydrol","volume":"1064","author":"Legrand","year":"2017","journal-title":"J. Chromatogr., B: Anal. Technol. Biomed. Life Sci."},{"issue":"10","key":"10.1016\/j.talanta.2023.124996_bib133","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26102903","article-title":"HPLC-UV and GC-MS methods for determination of chlorambucil and valproic acid in plasma for further exploring a new combined therapy of chronic lymphocytic leukemia","volume":"26","author":"Lipska","year":"2021","journal-title":"Molecules"},{"issue":"18","key":"10.1016\/j.talanta.2023.124996_bib134","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13184643","article-title":"Development and validation of an HPLC method for analysis of topotecan in human cerebrospinal fluid and its application in elimination evaluation of topotecan after intraventricular injection","volume":"13","author":"Yoshikawa","year":"2021","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.talanta.2023.124996_bib135","doi-asserted-by":"crossref","DOI":"10.1002\/bmc.4445","article-title":"Review of DBS methods as a quantitative tool for anticancer drugs","volume":"33","author":"Sulochana","year":"2019","journal-title":"Biomed. Chromatogr."},{"issue":"4","key":"10.1016\/j.talanta.2023.124996_bib188","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1177\/00045632221077183","article-title":"Development, validation, and application of a UPLC-MS\/MS method for vancomycin, norvancomycin, methotrexate, paclitaxel, and imatinib analysis in human plasma","volume":"59","author":"Chen","year":"2022","journal-title":"Ann. Clin. Biochem."},{"issue":"3","key":"10.1016\/j.talanta.2023.124996_bib136","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27030974","article-title":"A simple LC-MS\/MS method for the quantification of PDA-66 in human plasma","volume":"27","author":"Schwarz","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.talanta.2023.124996_bib137","doi-asserted-by":"crossref","DOI":"10.1016\/j.talanta.2019.120450","article-title":"Effective quantification of 11 tyrosine kinase inhibitors and caffeine in human plasma by validated LC-MS\/MS method with potent phospholipids clean- Application to therapeutic drug monitoring","volume":"208","author":"Koller","year":"2020","journal-title":"Talanta"},{"key":"10.1016\/j.talanta.2023.124996_bib138","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2019.112949","article-title":"A new high-performance liquid chromatography-tandem mass spectrometry method for the determination of sunitinib and N-desethyl sunitinib in human plasma: light-induced isomerism overtaking towards therapeutic drug monitoring in clinical routine","volume":"179","author":"Marangon","year":"2020","journal-title":"J. Pharmaceut. Biomed. Anal."},{"key":"10.1016\/j.talanta.2023.124996_bib232","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2021.114517","article-title":"Development and validation of an UPLC-MS\/MS method for simultaneous determination of fifteen targeted anti-cancer drugs in human plasma and its application in therapeutic drug monitoring","volume":"212","author":"Li","year":"2022","journal-title":"J. Pharmaceut. Biomed. Anal."},{"key":"10.1016\/j.talanta.2023.124996_bib233","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.928721","article-title":"Development and validation of a UPLC-MS\/MS method with volumetric absorptive microsampling to quantitate cyclophosphamide and 4-hydroxycyclophosphamide","volume":"13","author":"Harahap","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.talanta.2023.124996_bib234","doi-asserted-by":"crossref","DOI":"10.1016\/j.microc.2022.107549","article-title":"A novel polymer integrated Vertically-Oriented reduced graphene oxide sheets supported over palladium nanoparticles based sensor for Real-Time monitoring of Sorafenib; a Multi-kinase inhibitor in complex biological samples","volume":"180","author":"El-Zahry","year":"2022","journal-title":"Microchem. J."},{"key":"10.1016\/j.talanta.2023.124996_bib235","doi-asserted-by":"crossref","DOI":"10.1016\/j.chemosphere.2021.132928","article-title":"A green and sensitive guanine-based DNA biosensor for idarubicin anticancer monitoring in biological samples: a simple and fast strategy for control of health quality in chemotherapy procedure confirmed by docking investigation","volume":"291","author":"Karimi-Maleh","year":"2022","journal-title":"Chemosphere"},{"key":"10.1016\/j.talanta.2023.124996_bib236","doi-asserted-by":"crossref","DOI":"10.1016\/j.envres.2022.114114","article-title":"Design and fabrication of new anticancer sensor for monitoring of daunorubicin using 1-methyl-3-octylimidazolinium chloride and tin oxide\/nitrogen-doped graphene quantum dot nanocomposite electrochemical sensor","volume":"215","author":"Zare","year":"2022","journal-title":"Environ. Res."},{"issue":"4","key":"10.1016\/j.talanta.2023.124996_bib150","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1093\/jalm\/jfaa067","article-title":"Point-of-Care therapeutic drug monitoring for precision dosing of immunosuppressive drugs","volume":"5","author":"Taddeo","year":"2020","journal-title":"J. Appl. Lab. Med."},{"issue":"10","key":"10.1016\/j.talanta.2023.124996_bib153","article-title":"Expandable polymer assisted wearable personalized medicinal platform","volume":"5","author":"Babatain","year":"2020","journal-title":"Adv. Mater. Technol."},{"key":"10.1016\/j.talanta.2023.124996_bib147","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.jconrel.2021.08.027","article-title":"Nanobiotechnology-assisted therapies to manage brain cancer in personalized manner","volume":"338","author":"Nehra","year":"2021","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.talanta.2023.124996_bib240","doi-asserted-by":"crossref","DOI":"10.1177\/15330338231178403","article-title":"Recent advancements, limitations, and future perspectives of the use of personalized medicine in treatment of colon cancer","volume":"22","author":"Dey","year":"2023","journal-title":"Technol. Cancer Res. Treat."},{"issue":"10","key":"10.1016\/j.talanta.2023.124996_bib146","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1021\/acssensors.9b01616","article-title":"Electrochemical aptamer-based sensors for improved therapeutic drug monitoring and high-precision, feedback-controlled drug delivery","volume":"4","author":"Dauphin-Ducharme","year":"2019","journal-title":"ACS Sens."},{"key":"10.1016\/j.talanta.2023.124996_bib148","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.addr.2017.09.013","article-title":"Recent advances of controlled drug delivery using microfluidic platforms","volume":"128","author":"Sanjay","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.talanta.2023.124996_bib149","doi-asserted-by":"crossref","DOI":"10.1016\/j.dyepig.2019.107703","article-title":"Drug delivery platform comprising long-wavelength fluorogenic phenolo-cyanine dye for real-time monitoring of drug release","volume":"171","author":"Bokan","year":"2019","journal-title":"Dyes Pigments"},{"key":"10.1016\/j.talanta.2023.124996_bib151","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.113857","article-title":"Integration of personalized drug delivery systems into digital health","volume":"176","author":"Raijada","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.talanta.2023.124996_bib152","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.addr.2021.04.019","article-title":"Emerging 3D printing technologies for drug delivery devices: current status and future perspective","volume":"174","author":"Wang","year":"2021","journal-title":"Adv. Drug Deliv. Rev."}],"container-title":["Talanta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039914023007476?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039914023007476?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T13:22:27Z","timestamp":1758547347000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039914023007476"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":239,"alternative-id":["S0039914023007476"],"URL":"https:\/\/doi.org\/10.1016\/j.talanta.2023.124996","relation":{},"ISSN":["0039-9140"],"issn-type":[{"value":"0039-9140","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Overview of therapeutic drug monitoring and clinical practice","name":"articletitle","label":"Article Title"},{"value":"Talanta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.talanta.2023.124996","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"124996"}}